The efficacy of cyprodime, but not naltrindole and nor-binaltorphimine, to revert the effect of NFEPP indicates that the inhibition of tumor hyperalgesia evoked by NFEPP occurs through the activation of MOR exclusively. This evidence concerns the gene OPRM1 and neoplasm.